n n nn
PRESCRIBERS 1ST EDITION BY LUO K
n n n n n
AYINGO TEST BANK | 2024 UPDATE
n n n n n
, Table of Contents
n n
Chaptern 1:n AnnIntroductionnton Evidence-BasednClinicaln Practicen Guidelines ............................................... 3
Chaptern 2:nPharmacokineticsn /Chapter3:n Pharmacodynamics ..................................................................... 13
Chapter4:nPharmacogeneticsn andnPharmacogenomics................................................................................. 25
Chaptern 5:nPharmacologyn Acrossn thenLifenSpan .......................................................................................... 30
Chaptern 6:nDrug-TherapynPrescribingninnSpecialn Populations ..................................................................... 36
Chaptern 7:nDrugnDevelopmentn andnApproval .............................................................................................. 45
Chaptern8-Chaptern10:nFoundationsnofnPrescriptionnWritingnChaptern9:nResponsibleControlled-
SubstancenPrescribingnChaptern10:nAntibioticnStewardship ......................................................................... 51
Chaptern 11:n AppliednCalculationsn forn Prescribing....................................................................................... 58
Chaptern12-:nPromotingnAdherencenWithnPharmacotherapynII:nSystem-SpecificnandnPatient-
FocusednPrescribingnChaptern13:nPharmacotherapynfornEar,nNose,nMouth,nandThroatnConditionsn/Chaptern1
4:nPharmacotherapynfornEyenConditions ...................................................................................................... 67
Chaptern 15:nPharmacotherapyn forn Skinn Conditions ..................................................................................... 74
Chaptern 16:nPharmacotherapyn forn Neurologicn Conditions .......................................................................... 81
Chaptern 17:n Pharmacotherapyn forn Cardiovascularn Conditions .................................................................... 94
Chaptern 18:n Pharmacotherapyn forn Respiratoryn Conditions........................................................................ 106
Chaptern19:nPharmacotherapynfornGastrointestinalnConditionsnandnConditionsnRequiringNutritionalnSuppor
t .................................................................................................................................................................. 117
Chaptern 20:nPharmacotherapyn forn Genitourinaryn Conditions .................................................................... 128
Chaptern 21:nPharmacotherapynforn Renal,n Acid–Base,n Fluid,nandnElectrolytenDisorders ........................... 133
Chaptern 22:nPharmacotherapyn forn Musculoskeletalnandn Rheumatologicn Conditions ................................ 146
Chaptern 23:nTherapeuticn Applicationsn ofn Immunologyn andn Vaccines ...................................................... 158
Chaptern 24:nPharmacotherapyn forn EndocrinenDisorders ............................................................................ 163
Chaptern 25:nPharmacotherapyn forn Hematologicn Disorders ........................................................................ 174
Chaptern 26:n Hematology/Oncologyn andnSupportiven Carenforn thenNononcologist ..................................... 190
Chaptern 27:nPharmacotherapyn Relatedn tonWomen’sn Healthn Conditions ................................................... 196
Chaptern 28:nPharmacotherapyn RelatedntonMen’sn Healthn Conditions ......................................................... 211
Chaptern 29:n Pharmacotherapyn Relatedn tonTransgendern Care .................................................................... 217
Chaptern 30:nAntimicrobialnPharmacotherapy ............................................................................................ 224
Chaptern 31:nAntiretroviralnPharmacotherapy ............................................................................................. 235
Chaptern32:nPsychopharmacologynandnIntegrativenHealth:nCombinednTreatmentnofPsychiatricnandnNeuroco
gnitiven Conditions...................................................................................................................................... 247
Chaptern 33:nPharmacotherapyn forn PainnManagement ................................................................................ 257
Chaptern 34:nSubstancen UsenDisordern III:n HealthnPromotionnandnMaintenance.......................................... 267
Chaptern 35:nOver-the-Countern Medications .............................................................................................. 283
Chaptern 36:n Pharmacotherapynforn Obesity ................................................................................................ 291
,Chaptern1:nAnnIntroductionn tonEvidence-BasednClinicalnPracticenGuidelines
MULTIPLEnCHOICE
• Whatnisnthen primaryn purposen ofn then nursingn assessment?
A. Identifyingn underlyingn pathologicn conditions
B. Assistingn then physiciann innidentifyingn medicaln conditions
C. Determiningn then patientsnmentalnstatus
D. Exploringn patientn responsesn ton healthn problems
ANS:nD
Annursingnassessmentnisndonentonidentifynthenpatientsnresponsentonhealthnpro
blems.nDuringnthennursingnassessmentnphase,nancomprehensiveninformationn
basenisndevelopednthroughnanphysicalnexamination,nnursingnhistory,nmedicati
onnhistory,nandnprofessionalnobservation.nIdentifyingnunderlyingnpathologicn
conditionsnandnassistingnthenphysicianninnidentifyingnmedicalnconditionsnisnn
otnpartnofnthennursingnprocess.nDeterminingnthenpatientsn mentalnstatusn isnone
npartn ofnthen nursingn assessment,n butn itn isn notnthenprimarynpurpose.
DIF:nCognitivenLevel:nComprehensionn
REF:ndmn36nOBJ:n1n|n3nTOP:nNursingnP
rocessnStep:nAssessment
MSC:nNCLEXn Clientn Needsn Category:n Healthn Promotionn andn Maintenance
• Whatnisnthen basisn ofnthen NANDAnIn taxonomy?
A. Functionaln healthnpatterns
B. Humann responsen patterns
C. Basicn humann needs
D. Pathophysiologicn needs
ANS:nB
Then NANDAn In taxonomyn identifiesn humann responsen patterns.nFunction
alncomponentsnofnhealthnpatternsnarenlimitedntonactivity,nfluidnvolume,nnutri
tion,nselfncare,nandnsensorynperception.nBasicnhumannneedsncomprisenlessnt
hannmerelynhealthnpatterns.n Pathophysiologicnneedsn arennotnpartnofnthensco
penofnNANDAnI.
, DIF:nCognitivenLevel:nKnowledgenREF
:npp.n37-38nOBJ:n5nTOP:
Nursingn Processn Step:nDiagnosis
MSC:nNCLEXn Clientn Needsn Category:n Physiologicaln Integrity
• Whichntaskn isnincludedn innthenassessmentn stepn ofnthen nursingn process?
A. Establishingn patientn goals/outcomes
B. Implementingn then nursingn caren plann (NCP)
C. Measuringn goal/outcomen achievement
D. Collectingn andn communicatingn data
ANS:nD
Datanarencollectednandncommunicatedninnthenassessmentnphasenofnthennursin
gnprocess.nEstablishingngoalsnisnthenfunctionnofnplanning.
ImplementingnthenNCPnisnthenfunctionnofnimplementation.nMeasuringnoutco
menachievementnisnthenfunctionnofnevaluation.
DIF:nCognitivenLevel:nComprehensionn
REF:ndmn36nOBJ:n2n|n3nTOP:nNursingnP
rocessnStep:nAssessment
MSC:nNCLEXn Clientn Needsn Category:n Healthn Promotionn andn Maintenance
• Whichnstatementn regardingn nursingn diagnosesn isn accurate?
a. Nursingn diagnosesn remainnthen samen fornasn longnasn then diseasen isn present.
b. Nursingn diagnosesn aren writtenn ton identifyndiseasenstates.
c. Nursingn diagnosesn describen patientn problemsn thatn nursesn treat.
d. Nursingn diagnosesn identifyn causesn relatedn ton illness.
ANS:nC
Diagnosticnstatementsnidentifynproblemsnannursenisnindependentlynablentontr
eatnwithinnthenscopenofnprofessionalnpractice.nNursingndiagnosesnvarynwithnt
henchangingnconditionnofnthenpatient.nThenresponsenpatternsnarenuniquentonth
enpatientnandnarennotndiseasenspecific.nNursingndiagnosesndescribenthenpatie
ntsnhumannresponsenpattern.
DIF:n Cognitiven Level:n Comprehension